Horizon Therapeutics Public Ltd Co

VANGUARD GROUP INC

Report date

9/30/2023

Quarter

2023 Q3

Filed

12/18/2023

Shares

21,587,441

Value ($000)

2,497,451

Weight

0.1%

2019 Q4 - 2023 Q3 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	12/18/2023	2,497,451	0.1%	21,587,441	9/30/2023
2023 Q2	8/14/2023	2,215,854	0.1%	21,544,524	6/30/2023
2023 Q1	7/14/2023	2,352,320	0.1%	21,553,233	3/31/2023
2022 Q4	2/10/2023	2,416,669	0.1%	21,236,103	12/31/2022
2022 Q3	11/14/2022	1,316,812	0.0%	21,276,662	9/30/2022
2022 Q2	8/12/2022	1,668,768	0.0%	20,922,375	6/30/2022
2022 Q1	5/13/2022	2,138,801	0.1%	20,328,877	3/31/2022
2021 Q4	2/14/2022	2,170,145	0.0%	20,138,694	12/31/2021
2021 Q3	11/12/2021	2,193,540	0.1%	20,025,013	9/30/2021
2021 Q2	8/13/2021	1,865,884	0.0%	19,926,152	6/30/2021
2021 Q1	5/14/2021	1,887,225	0.1%	20,504,397	3/31/2021
2020 Q4	2/12/2021	1,457,166	0.0%	19,920,258	12/31/2020
2020 Q3	11/16/2020	1,495,562	0.0%	19,252,850	9/30/2020
2020 Q2	8/14/2020	986,797	0.0%	17,754,535	6/30/2020
2020 Q1	5/15/2020	519,676	0.0%	17,544,776	3/31/2020
2019 Q4	2/14/2020	618,636	0.0%	17,089,414	12/31/2019